Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma| Identifying, Managing and Mitigating Therapy-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Featuring perspectives from Drs Richard Furman, Lindsey Roeker and Daniel Lenihan, including the following topics: Introduction (0:00) Chronic Lymphocytic Leukemia (CLL) (1:37) Case: A woman in her early 70s with recurrent CLL and ibrutinib-associated atrial fibrillation — Warren S Brenner, MD (3:30) Case: A woman in her mid-40s with CLL in remission on ibrutinib who experiences ventricular fibrillation — Daniel J Lenihan, MD (29:16) Case: A man in his late 70s with CLL who receives obinutuzumab/venetoclax — Dr Brenner (38:22) Mantle Cell Lymphoma (MCL) (53:25) Novel Agents and Strategies in CLL and MCL (54:46) CME information and select publications